Black Rock Inc. Tempest Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 550,241 shares of TPST stock, worth $4.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
550,241
Previous 508,195
8.27%
Holding current value
$4.06 Million
Previous $1.99 Million
39.36%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TPST
# of Institutions
25Shares Held
1.97MCall Options Held
42.8KPut Options Held
72.9K-
Geode Capital Management, LLC Boston, MA433KShares$3.2 Million0.0% of portfolio
-
Ubs Group Ag324KShares$2.39 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA298KShares$2.2 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA115KShares$845,4450.0% of portfolio
-
Northern Trust Corp Chicago, IL99.4KShares$733,5050.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $76.9M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...